DEFA14A: Fossil Group Appoints Eugene Davis and Pamela Corrie to Board, Reaches Cooperation Agreement with Buxton Helmsley
Current Report Filing (8-K)
Fossil Group has appointed Eugene Davis and Pamela Corrie to its Board of Directors and entered into a cooperation agreement with Buxton Helmsley Active Value Fund, L.P.
Summary
- Fossil Group, Inc. has entered into a Cooperation Agreement with Buxton Helmsley Active Value Fund, L.P.
- Pamela B. Corrie has been appointed to the Board of Directors and the Nominating and Corporate Governance Committee.
- Eugene I. Davis has also been appointed to the Board and will serve on the Audit Committee.
- The size of the Board will not exceed ten directors until the earlier of the 2025 Annual Meeting or a change of control.
- Buxton has agreed to certain standstill restrictions and voting commitments as part of the agreement.
- Buxton has withdrawn its nomination notice and demand to inspect company records.
- Both new directors will receive standard non-employee director compensation, including an annual cash retainer of $140,000, pro-rated for the first quarter.
- They will also receive grants of restricted stock units, with vesting conditions based on continued service.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive. The addition of experienced directors and the resolution of a potential activist situation are positive developments. However, the company still faces challenges in its turnaround efforts.
Positives
- The appointment of new independent directors reflects Fossil's commitment to ongoing Board refreshment and governance excellence.
- The new directors bring decades of experience in retail operations, turnarounds, and finance and accounting.
- The agreement with Buxton Helmsley resolves potential activist challenges and provides stability.
- Buxton's withdrawal of its nomination notice and demand to inspect company records simplifies the upcoming annual meeting process.
Risks
- The Cooperation Agreement includes a termination date, potentially leading to future activist actions.
- The agreement contains standstill restrictions for Buxton, which could limit their ability to influence company decisions.
- The Board retains the right to make a Fiduciary Duty Determination, which could terminate Buxton's rights under the agreement.
Future Outlook
The Board will recommend nine nominees to stand for election at the 2024 Annual Meeting of Stockholders, consisting of the two new directors and seven other nominees, who are current directors, to be selected by the Board.
Management Comments
- Kevin Mansell, Chairman of the Board, said, 'We are pleased to have individuals of Genes and Pamelas stature and experience join the Fossil Board. Together, Gene and Pamela have tremendous operating, retail, turnaround, governance and leadership expertise, which we believe will be particularly valuable as we conduct a strategic review to maximize shareholder value, while continuing to advance the Companys Transform and Grow Plan.'
- Alexander Parker, Senior Managing Director at BHG, said, 'We are confident that with these additions to the Board, Fossil is well positioned to realize its full potential and drive value for all shareholders. We look forward to supporting Fossil as it executes its strategic plan.'
Industry Context
Activist investors often seek board representation to influence company strategy, particularly in turnaround situations. This agreement is a common resolution to avoid a proxy fight and allows the company to proceed with its strategic plan with some input from the activist investor.
Comparison to Industry Standards
- Cooperation agreements are a common tool used by companies to manage relationships with activist investors.
- The standstill provisions and voting commitments are typical terms in such agreements.
- The director compensation is consistent with industry standards for non-employee directors.
- The expense reimbursement cap is also within the typical range for such agreements.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Eugene I. Davis | March 24, 2024 | New appointment | |
| Director | Pamela B. Corrie | March 24, 2024 | New appointment as part of Cooperation Agreement |
Stakeholder Impact
- Shareholders: The agreement aims to maximize shareholder value through strategic review and board refreshment.
- Employees: The company's Transform and Grow Plan could impact employees.
- Customers: The company aims to deliver the best in design and innovation across its brands.
- Suppliers: The company's operations rely on a supply chain for key components and products.
Next Steps
- Fossil will file the Cooperation Agreement with the SEC.
- The Board will recommend nine nominees for election at the 2024 Annual Meeting of Stockholders.
- The company will continue its strategic review to maximize shareholder value and advance its Transform and Grow Plan.
Key Dates
| Date | Description |
|---|---|
| February 16, 2024 | Date of Buxton's nomination notice submitted to the Company. |
| February 26, 2024 | Date of Buxton's demand to inspect books and records. |
| March 24, 2024 | Date of the Cooperation Agreement and effective date of director appointments. |
| March 25, 2024 | Date of the Company's announcement of the director appointments. |
| April 12, 2023 | Date of the filing of the definitive proxy statement for the 2023 Annual Meeting of Stockholders. |
| June 28, 2023 | Date of the filing of a Current Report on Form 8-K. |
| August 9, 2023 | Date of the filing of a Current Report on Form 8-K. |
| March 13, 2024 | Date of the filing of a Current Report on Form 8-K. |
Keywords
Cooperation Agreement, Board of Directors, Pamela Corrie, Eugene Davis, Buxton Helmsley, Appointment, Governance, Directors
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.